Speaker

Sarah Gill

Executive Director, Clinical Monitoring

Sarah Gill is Executive Director, Clinical Monitoring at Caidya, where she leads global strategies in Risk-Based Quality Management and centralized monitoring. With over 15 years of experience progressing from CRA to senior leadership roles, including Head of Monitoring positions across the US and EU, Sarah brings deep operational expertise in clinical oversight. She is also an experienced trainer in monitoring and advanced monitoring, passionate about strengthening knowledge-sharing and evolving best practices in clinical operations.

Speaker's program

Day 1

11:30

-

12:00

The CRA Role in 2026: Are We Ready for What’s Next?

As clinical trials evolve, so does the CRA role. This panel brings together senior clinical operations leaders to discuss how oversight, expectations, and required competencies are changing — and whether organizations and CRAs are ready for what lies ahead.

Day 2

10:30

-

11:00

Monitoring in the time of RBQM – cross functionally delivering patient safety and data integrity

The regulations and methodology of monitoring have transformed from being exclusively on site and conducted by CRAs to a cross functional, data and signal driven, harmonised activity. With central monitoring, data management, medical monitoring, and other functions all supporting monitoring activity, what is the role of the modern CRA and how can CRAs best work with Central Monitoring and RBQM to be most effective?

May 12‒13, Barcelona, Spain

SIGN UP